cycloheximide has been researched along with Autoimmune Diabetes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ichikawa, F; Inada, C; Nonaka, K; Takane-Gyotoku, N; Yamada, K; Yuan, X | 1 |
| Rattner, JB; Shimoni, Y | 1 |
2 other study(ies) available for cycloheximide and Autoimmune Diabetes
| Article | Year |
|---|---|
Mouse islet cell lysis mediated by interleukin-1-induced Fas.
Topics: Animals; Antibodies, Monoclonal; Apoptosis; Autoimmune Diseases; Cells, Cultured; Chromates; Chromium Radioisotopes; Cycloheximide; Cytotoxicity, Immunologic; Diabetes Mellitus, Type 1; Dose-Response Relationship, Drug; Enzyme Inhibitors; fas Receptor; Gene Expression Regulation; Interleukin-1; Islets of Langerhans; Male; Mice; Mice, Inbred BALB C; omega-N-Methylarginine; Polymerase Chain Reaction; Protein Synthesis Inhibitors; Rats; RNA, Messenger; Sodium Compounds; Tumor Necrosis Factor-alpha | 1996 |
Type 1 diabetes leads to cytoskeleton changes that are reflected in insulin action on rat cardiac K(+) currents.
Topics: Animals; Colchicine; Cycloheximide; Cytochalasin D; Cytoskeleton; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Electric Conductivity; Fluorescent Antibody Technique, Indirect; Heart; Heart Ventricles; Insulin; Myocardium; Nucleic Acid Synthesis Inhibitors; Potassium Channels; Protein Synthesis Inhibitors; Rats; Rats, Sprague-Dawley; Tubulin | 2001 |